| 000 | 01506 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513121509.0 | ||
| 264 | 0 | _c19970717 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0025-729X | ||
| 024 | 7 |
_a10.5694/j.1326-5377.1997.tb123243.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMichael, M | |
| 245 | 0 | 0 |
_aAustralian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy. _h[electronic resource] |
| 260 |
_bThe Medical journal of Australia _cMay 1997 |
||
| 300 |
_a520-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBishop, J F | |
| 700 | 1 | _aLevi, J A | |
| 700 | 1 | _aBell, D R | |
| 700 | 1 | _aZalcberg, J R | |
| 700 | 1 | _aFriedlander, M L | |
| 700 | 1 | _aOlver, I N | |
| 700 | 1 | _aSmith, J G | |
| 700 | 1 | _aToner, G C | |
| 773 | 0 |
_tThe Medical journal of Australia _gvol. 166 _gno. 10 _gp. 520-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5694/j.1326-5377.1997.tb123243.x _zAvailable from publisher's website |
| 999 |
_c9177055 _d9177055 |
||